AwesomeCapital
Search This Blog
Friday, April 28, 2023
Mersana jumps 18% on ImmunoGen ovarian cancer treatment sales
Mersana Therapeutics closed up ~18% on Friday, benefitting from strong Q1 2023 sales of ImmunoGen's (IMGN) ovarian cancer treatment.
https://seekingalpha.com/news/3962278-mersana-jumps-18-rival-immunogen-ovarian-cancer-treatment-sales
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.